EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Magnesium Oxide Nanoparticle Supplementation (MgO NPS) on Fetuin-A Gene Expression and Insulin Resistance in Rats with Type 2 Diabetes

Atousa Nikbakht Sheibani, Mandana Gholami, Sahar Ghareh, Farshad Ghazalian

Gene, Cell and Tissue · 30.04.2026 · 13 (2)

DOI: 10.5812/gct-170849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene, Cell and Tissue, online erschienen am 30.04.2026. Verfasst von Atousa Nikbakht Sheibani und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fetuin-A is a liver-derived hepatokine and a major contributor to insulin resistance in type 2 diabetes mellitus (T2DM). Individuals with T2DM frequently have low magnesium levels, which are associated with impaired metabolic health; however, standard magnesium supplements have shown variable therapeutic efficacy.

Objectives

This study aimed to evaluate the effects of magnesium oxide nanoparticle supplementation (MgO NPS) on hepatic Fetuin-A mRNA expression and insulin resistance parameters in an experimental rat model of T2DM.

Methods

A total of 24 male Wistar rats were equally allocated to three experimental groups (n = 8 per group): healthy control (HC), diabetic control (DC), and diabetic rats receiving MgO NPS (DS) at a daily dose of 300 mg/kg by oral gavage for 8 weeks. Diabetes was induced by intraperitoneal administration of nicotinamide (110 mg/kg), followed by streptozotocin (60 mg/kg).

Results

Diabetic rats exhibited significantly higher fetuin-A expression and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) values than healthy controls (P < 0.001). MgO NPS significantly reduced both fetuin-A gene expression (1.05 ± 0.10 vs. 1.61 ± 0.16, P < 0.001) and HOMA-IR (1.16 ± 0.16 vs. 1.65 ± 0.25, P = 0.001) in diabetic rats.

Conclusions

An 8-week course of MgO NPS significantly ameliorated insulin resistance in diabetic rats, with the downregulation of hepatic Fetuin-A expression as a plausible underlying mechanism. These findings suggest that nano-formulated magnesium may represent a promising candidate for future therapeutic approaches targeting hepatokine-driven insulin resistance in T2DM.

Zitieren

APA

Sheibani, A. N., Gholami, M., Ghareh, S., & Ghazalian, F. (2026). The Effect of Magnesium Oxide Nanoparticle Supplementation (MgO NPS) on Fetuin-A Gene Expression and Insulin Resistance in Rats with Type 2 Diabetes. Gene, Cell and Tissue, 13(2). https://doi.org/10.5812/gct-170849

Vancouver

Sheibani AN, Gholami M, Ghareh S, Ghazalian F. The Effect of Magnesium Oxide Nanoparticle Supplementation (MgO NPS) on Fetuin-A Gene Expression and Insulin Resistance in Rats with Type 2 Diabetes. Gene, Cell and Tissue. 2026;13(2). doi:10.5812/gct-170849

BibTeX
@article{Sheibani2026,
  author = {Sheibani, Atousa Nikbakht and Gholami, Mandana and Ghareh, Sahar and Ghazalian, Farshad},
  title = {The Effect of Magnesium Oxide Nanoparticle Supplementation (MgO NPS) on Fetuin-A Gene Expression and Insulin Resistance in Rats with Type 2 Diabetes},
  journal = {Gene, Cell and Tissue},
  year = {2026},
  volume = {13},
  number = {2},
  doi = {10.5812/gct-170849}
}
Kostenlos starten →